|
|
||||||||||
|
J Am Coll Cardiol, 1995; 25:1354-1361 © 1995 by the American College of Cardiology Foundation |
Charles A. Dana Research Institute, Beth Israel Hospital, Boston, Massachusetts 02215, USA.
OBJECTIVES. We sought to validate the safety of transesophageal echocardiographically guided early cardioversion in conjunction with short-term anticoagulation as a strategy for guiding early cardioversion in hospitalized patients with atrial fibrillation. BACKGROUND. Because atrial thrombi are poorly seen by conventional imaging techniques, several weeks of prophylactic anticoagulation is routinely prescribed before cardioversion. Transesophageal echocardiography is a superior test for identifying atrial thrombi; preliminary feasibility studies have supported its use to guide early cardioversion for patients in whom no thrombus is observed, but safety has not been validated in any large series. METHODS. All patients admitted to hospital with atrial fibrillation during a 4.5-year period were screened. The inclusion criterion was a clinical duration of atrial fibrillation > 2 days or of unknown duration. Patients received anticoagulation with heparin/warfarin and underwent conventional transthoracic echocardiography followed by transesophageal study. Patients in whom transesophageal echocardiography revealed no atrial thrombus underwent pharmacologic or electrical cardioversion followed by warfarin therapy for 1 month. Cardioversion was deferred in patients with evidence of atrial thrombi, and they received prolonged warfarin treatment. RESULTS. Two hundred thirty-three patients (86% of those eligible) agreed to participate, and 230 underwent transesophageal echocardiography. Transesophageal echocardiography identified 40 atrial thrombi (left atrium 34, right atrium 6) in 34 patients (15%). One hundred eighty-six (95%) of 196 patients without thrombi had successful cardioversion to sinus rhythm, all without prolonged anticoagulation, and none (0%, 95% confidence interval 0% to 1.6%) experienced a clinical thromboembolic event. Eighteen patients with atrial thrombi underwent uneventful cardioversion after prolonged anticoagulation. CONCLUSIONS. Compared with smaller series that have shown only feasibility, this large prospective and consecutive study of patients undergoing transesophageal echocardiographically facilitated early cardioversion in conjunction with short-term anticoagulation validates the safety of this strategy. This treatment algorithm has a safety profile similar to conventional therapy and minimizes both the period of anticoagulation and the overall duration of atrial fibrillation.
This article has been cited by other articles:
![]() |
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, October 7, 2008; 118(15): e523 - e661. [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142. [Full Text] [PDF] |
||||
![]() |
D. E. Singer, G. W. Albers, J. E. Dalen, M. C. Fang, A. S. Go, J. L. Halperin, G. Y. H. Lip, and W. J. Manning Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 546S - 592S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Klein, S. E. Jasper, W. E. Katz, J. F. Malouf, L. A. Pape, M. F. Stoddard, C. Apperson-Hansen, E. A. Lieber, and The ACUTE II Steering and Publications Committee F The use of enoxaparin compared with unfractionated heparin for short-term antithrombotic therapy in atrial fibrillation patients undergoing transoesophageal echocardiography-guided cardioversion: Assessment of Cardioversion Using Transoesophageal Echocardiography (ACUTE) II randomized multicentre study Eur. Heart J., December 1, 2006; 27(23): 2858 - 2865. [Abstract] [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 651 - 745. [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246. [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): e257 - e354. [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148. [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): 598 - 675. [Full Text] [PDF] |
||||
![]() |
A Maltagliati, C A Galli, G Tamborini, A Calligaris, E Doria, R Salehi, and M Pepi Usefulness of transoesophageal echocardiography before cardioversion in patients with atrial fibrillation and different anticoagulant regimens Heart, July 1, 2006; 92(7): 933 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Strandberg, M.J. P. Raatikainen, M. Niemela, M. Luotolahti, J. Hartiala, and K.E. J. Airaksinen Clinical practicality and predictive value of transoesophageal echocardiography in early cardioversion of atrial fibrillation Europace, June 1, 2006; 8(6): 408 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Spuentrup, B. Fausten, S. Kinzel, A. J. Wiethoff, R. M. Botnar, P. B. Graham, S. Haller, M. Katoh, E. C. Parsons Jr, W. J. Manning, et al. Molecular Magnetic Resonance Imaging of Atrial Clots in a Swine Model Circulation, July 19, 2005; 112(3): 396 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
O A Obel, L Luddington, N Maarouf, K Aytemir, C Ekwall, M Malik, and A J Camm Effects of ventricular rate and regularity on the velocity and magnitude of left atrial appendage flow in atrial fibrillation Heart, June 1, 2005; 91(6): 764 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Singer, G. W. Albers, J. E. Dalen, A. S. Go, J. L. Halperin, and W. J. Manning Antithrombotic Therapy in Atrial Fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 429S - 456S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.A Sallach and A.L Klein Subtherapeutic anticoagulation: the bane of conventional anticoagulation for cardioversion of atrial fibrillation Eur J Echocardiogr, August 1, 2004; 5(4): 239 - 242. [Full Text] [PDF] |
||||
![]() |
G Corrado, S Beretta, L Sormani, G Tadeo, G Foglia-Manzillo, L.M Tagliagambe, and M Santarone Prevalence of atrial thrombi in patients with atrial fibrillation/flutter and subtherapeutic anticoagulation prior to cardioversion Eur J Echocardiogr, August 1, 2004; 5(4): 257 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Aronow Management of the Older Person With Atrial Fibrillation J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2002; 57(6): M352 - 363. [Abstract] [Full Text] |
||||
![]() |
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology Eur. Heart J., October 2, 2001; 22(20): 1852 - 1923. [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1266 - 1266. [Full Text] [PDF] |
||||
![]() |
J. Hirsh, S. S. Anand, J. L. Halperin, and V. Fuster Guide to Anticoagulant Therapy: Heparin : A Statement for Healthcare Professionals From the American Heart Association Arterioscler. Thromb. Vasc. Biol., July 1, 2001; 21 (7): e9 - e9. [Full Text] [PDF] |
||||
![]() |
J. Hirsh, S. S. Anand, J. L. Halperin, and V. Fuster Guide to Anticoagulant Therapy: Heparin : A Statement for Healthcare Professionals From the American Heart Association Circulation, June 19, 2001; 103(24): 2994 - 3018. [Full Text] [PDF] |
||||
![]() |
G Corrado, A Sgalambro, A Mantero, F Gentile, M Gasparini, R Bufalino, A Morabito, G Trocino, R Schiavina, S Mandorla, et al. Thromboembolic risk in atrial flutter. The FLASIEC (FLutterAtrialeSocietaIaliana diEcografiaCardiovascolare) multicentre study Eur. Heart J., June 2, 2001; 22(12): 1042 - 1051. [Abstract] [PDF] |
||||
![]() |
A. L. Klein, R. A. Grimm, R. D. Murray, C. Apperson-Hansen, R. W. Asinger, I. W. Black, R. Davidoff, R. Erbel, J. L. Halperin, D. A. Orsinelli, et al. Use of Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation N. Engl. J. Med., May 10, 2001; 344(19): 1411 - 1420. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Falk Atrial Fibrillation N. Engl. J. Med., April 5, 2001; 344(14): 1067 - 1078. [Full Text] [PDF] |
||||
![]() |
S. Kamath and G.Y.H. Lip Cardioversion of atrial fibrillation or flutter: a 'stunning' problem Eur. Heart J., March 2, 2001; 22(6): 520 - 521. [PDF] |
||||
![]() |
A. L. Klein, R. D. Murray, and R. A. Grimm Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation J. Am. Coll. Cardiol., March 1, 2001; 37(3): 691 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Roijer, J Eskilsson, and B Olsson Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion Eur. Heart J., May 2, 2000; 21(10): 837 - 847. [Abstract] [PDF] |
||||
![]() |
M. M. Scheinman Mechanisms of atrial fibrillation: is a cure at hand? J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1687 - 1692. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.U Khand, A.C Rankin, G.C Kaye, and J.G.F Cleland Systematic review of the management of atrial fibrillation in patients with heart failure Eur. Heart J., April 2, 2000; 21(8): 614 - 632. [Abstract] [PDF] |
||||
![]() |
G. Corrado, M. Santarone, S. Beretta, G. Tadeo, L.M. Tagliagambe, G. Foglia-Manzillo, M. Spata, E. Miglierina, F. Acquati, and M. Santarone Early cardioversion of atrial fibrillation and atrial flutter guided by transoesophageal echocardiography: A single centre 8{middle dot}5-year experience Europace, January 1, 2000; 2(2): 119 - 126. [Abstract] [PDF] |
||||
![]() |
M J Weigner, S E Katz, P S Douglas, and W J Manning Left atrial appendage anatomy and function: short term response to sustained atrial fibrillation Heart, November 1, 1999; 82(5): 555 - 558. [Abstract] [Full Text] |
||||
![]() |
H.-W. M. Breuer, W. J. Manning, and D. I. Silverman Spontaneous Echo Contrast and Atrial Fibrillation • Response Circulation, February 23, 1999; 99 (7): 975 - 978. [Full Text] [PDF] |
||||
![]() |
G. Corrado, G. Tadeo, S. Beretta, L. M. Tagliagambe, G. F. Manzillo, M. Spata, and M. Santarone Atrial Thrombi Resolution After Prolonged Anticoagulation in Patients With Atrial Fibrillation: A Transesophageal Echocardiographic Study Chest, January 1, 1999; 115(1): 140 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. I. Silverman and W. J. Manning Role of Echocardiography in Patients Undergoing Elective Cardioversion of Atrial Fibrillation Circulation, August 4, 1998; 98(5): 479 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Veinot, P. J. Harrity, F. Gentile, B. K. Khandheria, K. R. Bailey, J. T. Eickholt, J. B. Seward, A. J. Tajik, and W. D. Edwards Anatomy of the Normal Left Atrial Appendage : A Quantitative Study of Age-Related Changes in 500 Autopsy Hearts: Implications for Echocardiographic Examination Circulation, November 4, 1997; 96(9): 3112 - 3115. [Abstract] [Full Text] |
||||
![]() |
W. N. Irani, P. A. Grayburn, and I. Afridi Prevalence of Thrombus, Spontaneous Echo Contrast, and Atrial Stunning in Patients Undergoing Cardioversion of Atrial Flutter: A Prospective Study Using Transesophageal Echocardiography Circulation, February 18, 1997; 95(4): 962 - 966. [Abstract] [Full Text] |
||||
![]() |
E. N. Prystowsky, D. W. Benson Jr, V. Fuster, R. G. Hart, G. N. Kay, R. J. Myerburg, G. V. Naccarelli, and D. G. Wyse Management of Patients With Atrial Fibrillation : A Statement for Healthcare Professionals From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association Circulation, March 15, 1996; 93(6): 1262 - 1277. [Full Text] |
||||
![]() |
B. D. Lindsay Obliteration of the Left Atrial Appendage: A Concept Worth Testing Ann. Thorac. Surg., February 1, 1996; 61(2): 515 - 515. [Full Text] |
||||
![]() |
J. A. Odell, J. L. Blackshear, E. Davies, W. J. Byrne, C. F. Kollmorgen, W. D. Edwards, and T. A. Orszulak Thoracoscopic Obliteration of the Left Atrial Appendage: Potential for Stroke Reduction? Ann. Thorac. Surg., February 1, 1996; 61(2): 565 - 569. [Abstract] [Full Text] |
||||
![]() |
H. G. Bogren, A. M. Lam, Y. Enokawa, Y. Seko, Y. Yazaki, W. G. Daniel, and A. Mugge Transesophageal Echocardiography N. Engl. J. Med., October 26, 1995; 333(17): 1153 - 1154. [Full Text] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |